William Blair Issues Positive Outlook for DVAX Earnings
Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) – Equities research analysts at William Blair increased their Q3 2025 EPS estimates for Dynavax Technologies in a research note issued to investors on Wednesday, May 7th. William Blair analyst M. Phipps now anticipates that the biopharmaceutical company will post earnings per share of $0.15 for the quarter, […]
